Skip to main content
Log in

Effect of Costus pictus per se and in combination with Metformin and Enalapril in streptozotocin induced diabetic nephropathy in rats

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Aim

The present study was designed to investigate the effect of methanolic extract of Costus pictus (MECP) per se and in combination with drugs (Metformin and Enalapril) used in clinical practice in streptozotocin (STZ) induced diabetic nephropathy (DN) in rats.

Methods

Diabetes was induced in male Wistar rats by a single injection of STZ (50 mg/kg i.p.). After 28 days diabetic rats were divided into six groups. Two groups were treated with MECP (200 mg/kg p.o.), MECP (400 mg/kg p.o.) respectively; one group was treated with metformin (225 mg/kg), enalapril (3.2 mg/kg) combination; and two groups were treated with a combination of metformin, enalapril and MECP (200 mg/kg) and combination of metformin, enalapril and MECP (400 mg/kg) respectively. One group was kept as diabetic control. At the end of the study, body weight, kidney weight, and kidney hypertrophy index were evaluated. Biochemical and antioxidant parameters were evaluated. TGF-β levels in serum were estimated. Histopathology of the kidney was also studied.

Results

The combination therapy showed a significant increase in the body weight, lowered blood glucose levels and ameliorated kidney hypertrophy index in STZ induced diabetic nephropathy in rats. It also normalized the altered levels of serum and urine parameters. Histopathological evaluation revealed that combination therapy reduced the vacuolar degeneration of tubules.

Conclusions

The results indicate that combination therapy of metformin, enalapril, and MECP has beneficial effects in management of diabetic nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Laddha AP, Kulkarni YA. Tannins and vascular complications of Diabetes: An update [Internet]. Phytomedicine. Urban & Fischer; 2019 [cited 2019 Jan 14]. p. 229–45. Available from: https://www.sciencedirect.com/science/article/pii/S0944711318305464.

  2. Garud MS, Kulkarni YA. Gallic acid attenuates type I diabetic nephropathy in rats. Chem Biol Interact [Internet]. 2018 [cited 2018 Jun 26];282:69–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29331653.

  3. Article R, Ayurvedic I, Journal M. Role of Traditional Medicine in Improving the Socio-Economic. 1986 [cited 2019 Jan 14]; Available from: www.aims.in.

  4. Majumdar M, Parihar PS. Antibacterial, antioxidant and antiglycation potential of Costus pictus from Southern region, India. Asian J Plant Sci Res [Internet]. 2012;2:95–101. [cited 2019 Jan 14 ;:. Available from: www.pelagiaresearchlibrary.com.

    Google Scholar 

  5. Don D, Remya R, Daniel M. Phytochemical and pharmacognostic investigation of antidiabetic Costus. 2012 [cited 2019 Jan 14];3:30–9. Available from: https://www.nresearchgate.net/publication/265877259.

  6. Kulkarni YA, Garud MS, Oza MJ, Barve KH, Gaikwad AB. Diabetes, diabetic complications, and flavonoids. Fruits, Veg Herbs Bioact Foods Heal Promot [Internet]. Academic Press; 2016 [cited 2019 Jan 14]. p. 77–104. Available from: https://www.sciencedirect.com/science/article/pii/B9780128029725000056.

  7. Moneim AA, Abd El-Twab SM, Ashour MB, Yousef AI, Yousef AI. Hepato-renal protective effects of gallic acid and p-coumaric acid in nicotinamide/streptozotocin-induced diabetic rats. Int J Bioassays [Internet]. International Journal of Bioassays; 2016 [cited 2019 Jan 14];5:4641. Available from: http://ijbio.com/index.php/ijb/article/view/1020.

  8. Garud MS, Kulkarni YA. Attenuation of renal damage in type I diabetic rats by umbelliferone – a coumarin derivative. Pharmacol Reports [Internet]. Elsevier; 2017 [cited 2019 Jan 14];69:1263–9. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1734114017301366.

  9. Garud MS, Kulkarni YA. Eugenol ameliorates renal damage in streptozotocin-induced diabetic rats. Flavour Fragr J; 2017; 32:54–62. Available from: https://doi.org/10.1002/ffj.3357.

  10. Wang GG, Lu XH, Li W, Zhao X, Zhang C. Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evidence-based Complement Altern Med [Internet]. Hindawi; 2011 [cited 2019 Jan 14];2011:323171. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21584231.

  11. Elberry AA, Harraz FM, Ghareib SA, Gabr SA, Nagy AA, Abdel-Sattar E. Methanolic extract of Marrubium vulgare ameliorates hyperglycemia and dyslipidemia in streptozotocin-induced diabetic rats. Int J Diabetes Mellit [Internet].; 2015 [cited 2019 Jan 14];3:37–44. Available from: https://www.sciencedirect.com/science/article/pii/S1877593411000051.

  12. Vasavada N, Agarwal R. Role of oxidative stress in diabetic nephropathy [Internet]. Adv. Chronic Kidney Dis. 2005 [cited 2019 Jan 14]. p. 146–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20939814.

  13. Gaedeke J, Noble NA, Border WA. Curcumin blocks multiple sites of the TGF-β signaling cascade in renal cells. Kidney Int [Internet]. 2004 [cited 2019 Jan 14];66:112–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15200418.

  14. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-de la Cruz MC, Hong SW, Isono M, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci [Internet]. 2000 [cited 2019 Jan 14];97:8015–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10859350.

  15. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest [Internet]. 2001 [cited 2019 Jan 14];108:1853–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11748269.

  16. Gaedeke J, Noble NA, Border WA. Angiotensin II and progressive renal insufficiency. Curr Hypertens Rep [Internet]. 2002 [cited 2019 Jan 14];4:403–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12217260.

  17. Morsy MA, Ibrahim SA, Amin EF, Kamel MY, Abdelwahab SA, Hassan MK. Carvedilol ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Biomed Res Int [Internet]. Hindawi Limited; 2014 [cited 2019 Jan 14];2014:105214. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24991534.

  18. Abo-Salem OM, El-Edel RH, Harisa GEI, El-Halawany N, Ghonaim MM. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters. Pak J Pharm Sci [Internet]. 2009 [cited 2019 Jan 14];22:205–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19339234.

  19. Jin Y, Shi Y, Zou Y, Miao C, Sun B, Li C. Fenugreek prevents the development of STZ-induced diabetic nephropathy in a rat model of diabetes. Evidence-based Complement Altern Med [Internet]. 2014 [cited 2019 Jan 14];2014:1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25057273.

  20. Belhekar SN, Chaudhari PD, Pandhare RB, Pawar AR. Effect of polyherbal and allopolyherbal formulation on streptozotocin-nicotinamide induced diabetic nephropathy in rats. Int J Toxicol Pharmacol Res [Internet]. 2016;8:138–45. [cited 2019 Jan 14 ;:. Available from: www.ijtpr.com.

    Google Scholar 

  21. Mestry SN, Dhodi JB, Kumbhar SB, Juvekar AR. Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract. J Tradit Complement Med [Internet]. 2017 [cited 2018 Jun 26];7:273–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28725620.

  22. Kiran G, Nandini CD, Ramesh HP, Salimath PV. Progression of early phase diabetic nephropathy in streptozotocin-induced diabetic rats: Evaluation of various kidney-related parameters. Indian J Exp Biol [Internet]. 2012 [cited 2019 Jan 14];50:133–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22670476.

  23. Li X, Hu J, Zhang Q, Sun X, Li S. Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-Β1 and VEGF. Br J Pharmacol [Internet]. Wiley-Blackwell; 2009 [cited 2019 Jan 14];157:994–1003. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19466989.

  24. Braga Gomes K, Fontana Rodrigues K, Fernandes AP. The Role of Transforming Growth Factor-Beta in Diabetic Nephropathy. Int J Med Genet [Internet]. Hindawi; 2014 [cited 2019 Jan 14];2014:1–6. Available from: http://www.hindawi.com/archive/2014/180270/.

Download references

Author information

Authors and Affiliations

Authors

Contributions

MS and YK designed the experiment. GS performed the experiment. GS, MS and YK analysed the data and wrote the manuscript.

Corresponding author

Correspondence to Mrinal Sanaye.

Ethics declarations

Conflict of interest

Authors have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanaye, M., Sathyapal, G. & Kulkarni, Y.A. Effect of Costus pictus per se and in combination with Metformin and Enalapril in streptozotocin induced diabetic nephropathy in rats. J Diabetes Metab Disord 21, 1349–1358 (2022). https://doi.org/10.1007/s40200-022-01065-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-022-01065-5

Keywords

Navigation